A blueprint for cancer screening and early detection

Advancing screening’s contribution to cancer control

Richard C. Wender, Otis Brawley, Stacey A. Fedewa, Ted Gansler, Robert A. Smith

Research output: Contribution to journalArticle

Abstract

From the mid-20th century, accumulating evidence has supported the introduction of screening for cancers of the cervix, breast, colon and rectum, prostate (via shared decisions), and lung. The opportunity to detect and treat precursor lesions and invasive disease at a more favorable stage has contributed substantially to reduced incidence, morbidity, and mortality. However, as new discoveries portend advancements in technology and risk-based screening, we fail to fulfill the greatest potential of the existing technology, in terms of both full access among the target population and the delivery of state-of-the art care at each crucial step in the cascade of events that characterize successful cancer screening. There also is insufficient commitment to invest in the development of new technologies, incentivize the development of new ideas, and rapidly evaluate promising new technology. In this report, the authors summarize the status of cancer screening and propose a blueprint for the nation to further advance the contribution of screening to cancer control.

Original languageEnglish (US)
Pages (from-to)50-79
Number of pages30
JournalCA Cancer Journal for Clinicians
Volume69
Issue number1
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Fingerprint

Early Detection of Cancer
Technology
Neoplasms
Health Services Needs and Demand
Rectal Neoplasms
Uterine Cervical Neoplasms
Prostate
Colon
Breast Neoplasms
Morbidity
Lung
Mortality
Incidence

Keywords

  • breast neoplasms
  • cervical neoplasms
  • colorectal neoplasms
  • lung neoplasms
  • mass screening
  • prostate neoplasms

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

A blueprint for cancer screening and early detection : Advancing screening’s contribution to cancer control. / Wender, Richard C.; Brawley, Otis; Fedewa, Stacey A.; Gansler, Ted; Smith, Robert A.

In: CA Cancer Journal for Clinicians, Vol. 69, No. 1, 01.01.2019, p. 50-79.

Research output: Contribution to journalArticle

Wender, Richard C. ; Brawley, Otis ; Fedewa, Stacey A. ; Gansler, Ted ; Smith, Robert A. / A blueprint for cancer screening and early detection : Advancing screening’s contribution to cancer control. In: CA Cancer Journal for Clinicians. 2019 ; Vol. 69, No. 1. pp. 50-79.
@article{e1d2bcd270e240778d4595be832c7bef,
title = "A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control",
abstract = "From the mid-20th century, accumulating evidence has supported the introduction of screening for cancers of the cervix, breast, colon and rectum, prostate (via shared decisions), and lung. The opportunity to detect and treat precursor lesions and invasive disease at a more favorable stage has contributed substantially to reduced incidence, morbidity, and mortality. However, as new discoveries portend advancements in technology and risk-based screening, we fail to fulfill the greatest potential of the existing technology, in terms of both full access among the target population and the delivery of state-of-the art care at each crucial step in the cascade of events that characterize successful cancer screening. There also is insufficient commitment to invest in the development of new technologies, incentivize the development of new ideas, and rapidly evaluate promising new technology. In this report, the authors summarize the status of cancer screening and propose a blueprint for the nation to further advance the contribution of screening to cancer control.",
keywords = "breast neoplasms, cervical neoplasms, colorectal neoplasms, lung neoplasms, mass screening, prostate neoplasms",
author = "Wender, {Richard C.} and Otis Brawley and Fedewa, {Stacey A.} and Ted Gansler and Smith, {Robert A.}",
year = "2019",
month = "1",
day = "1",
doi = "10.3322/caac.21550",
language = "English (US)",
volume = "69",
pages = "50--79",
journal = "Ca-A Cancer Journal for Clinicians",
issn = "0007-9235",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - A blueprint for cancer screening and early detection

T2 - Advancing screening’s contribution to cancer control

AU - Wender, Richard C.

AU - Brawley, Otis

AU - Fedewa, Stacey A.

AU - Gansler, Ted

AU - Smith, Robert A.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - From the mid-20th century, accumulating evidence has supported the introduction of screening for cancers of the cervix, breast, colon and rectum, prostate (via shared decisions), and lung. The opportunity to detect and treat precursor lesions and invasive disease at a more favorable stage has contributed substantially to reduced incidence, morbidity, and mortality. However, as new discoveries portend advancements in technology and risk-based screening, we fail to fulfill the greatest potential of the existing technology, in terms of both full access among the target population and the delivery of state-of-the art care at each crucial step in the cascade of events that characterize successful cancer screening. There also is insufficient commitment to invest in the development of new technologies, incentivize the development of new ideas, and rapidly evaluate promising new technology. In this report, the authors summarize the status of cancer screening and propose a blueprint for the nation to further advance the contribution of screening to cancer control.

AB - From the mid-20th century, accumulating evidence has supported the introduction of screening for cancers of the cervix, breast, colon and rectum, prostate (via shared decisions), and lung. The opportunity to detect and treat precursor lesions and invasive disease at a more favorable stage has contributed substantially to reduced incidence, morbidity, and mortality. However, as new discoveries portend advancements in technology and risk-based screening, we fail to fulfill the greatest potential of the existing technology, in terms of both full access among the target population and the delivery of state-of-the art care at each crucial step in the cascade of events that characterize successful cancer screening. There also is insufficient commitment to invest in the development of new technologies, incentivize the development of new ideas, and rapidly evaluate promising new technology. In this report, the authors summarize the status of cancer screening and propose a blueprint for the nation to further advance the contribution of screening to cancer control.

KW - breast neoplasms

KW - cervical neoplasms

KW - colorectal neoplasms

KW - lung neoplasms

KW - mass screening

KW - prostate neoplasms

UR - http://www.scopus.com/inward/record.url?scp=85056782350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056782350&partnerID=8YFLogxK

U2 - 10.3322/caac.21550

DO - 10.3322/caac.21550

M3 - Article

VL - 69

SP - 50

EP - 79

JO - Ca-A Cancer Journal for Clinicians

JF - Ca-A Cancer Journal for Clinicians

SN - 0007-9235

IS - 1

ER -